PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-01-09

Date Title Company
09-Jan-2024 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease OKYO Pharma
09-Jan-2024 iTeos Announces 2024 Strategic Priorities and Anticipated Milestones iTeos Therapeutics
09-Jan-2024 Cherwell Joins the AnalytiChem Group of Companies Cherwell
09-Jan-2024 AT-HOME APP LAUNCHES AS NHS REVEALS ALMOST 2M HOSPITALISED DUE TO UTI Newfoundland
09-Jan-2024 Lynx.MD Expands Gastroenterology Data Repository with Allied Digestive Health Collaboration AccessWire
09-Jan-2024 Mentavi Health Partnering with Colleges, Universities to Help Students with Mental Health Services   AccessWire
09-Jan-2024 HealthMe Partners With Boston Hernia to Simplify Direct-Pay for Surgery Patients AccessWire
09-Jan-2024 Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialise OHB-607, a potentially transformative neonatal therapy Chiesi Group
09-Jan-2024 Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program AccessWire
09-Jan-2024 NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network AccessWire
09-Jan-2024 Rancho Biosciences Welcomes Seventh Member to Single-Cell Data Science Consortium Newswire
09-Jan-2024 Mazree and Capstone Health Alliance Join Forces to Revolutionize Equipment Value Recovery in Healthcare AccessWire
09-Jan-2024 Rancho Biosciences Welcomes Seventh Member to Single-Cell Data Science Consortium AccessWire
09-Jan-2024 Nutrigene Launches Personalised Development Program to Intersect Genetics and Learning through DNA Nutrigene Modern Sciences Sdn. Bhd
09-Jan-2024 AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS(R) for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients AccessWire
09-Jan-2024 Mainz Biomed Provides Year-End Corporate Review 2023 Mainz BioMed N.V.
09-Jan-2024 Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued AccessWire
09-Jan-2024 Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX AccessWire
09-Jan-2024 Levity Products, Inc Announces New Distribution Agreement with Domrex Pharma, Inc to Expand Market Reach AccessWire
09-Jan-2024 AMLo Biosciences publish pivotal data for diagnostic biomarker technology AMBLor® in identifying melanomas at low risk of metastasis AMLo Biosciences